Search Results - Sharon Merims
- Showing 1 - 4 results of 4
-
1
-
2
SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint by Emma Hajaj, Galit Eisenberg, Shiri Klein, Shoshana Frankenburg, Sharon Merims, Inna Ben David, Thomas Eisenhaure, Sarah E Henrickson, Alexandra Chloé Villani, Nir Hacohen, Nathalie Abudi, Rinat Abramovich, Jonathan E Cohen, Tamar Peretz, Andre Veillette, Michal Lotem
Published in eLife (2020-03-01)Get full text
Article -
3
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade by Michal Lotem, Sharon Merims, Stephen Frank, Tamar Hamburger, Aviram Nissan, Luna Kadouri, Jonathan Cohen, Ravid Straussman, Galit Eisenberg, Shoshana Frankenburg, Einat Carmon, Bilal Alaiyan, Shlomo Shneibaum, Zeynep Ozge Ayyildiz, Murat Isbilen, Kerem Mert Senses, Ilan Ron, Hanna Steinberg, Yoav Smith, Eitan Shiloni, Ali Osmay Gure, Tamar Peretz
Published in Journal of Immunology Research (2016-01-01)Get full text
Article -
4
Impact of COVID-19 on cutaneous squamous cell carcinoma severity in a tertiary referral center in Israel: Lessons for future pandemics by Deborah Korn, MD, Sivan Sheffer-Levi, MD, Maayan Eitan-Wexler, PhD, Stephanie Ben-Shushan, MD, Mordechai Avner, MD, Nir Hirshhorn, MD, Meni Bracha, MD, Alexander Mali, MD, Roni Shereberk-Hasidim, MD, Sharon Merims, MD, Aron Popovtzer, MD, Vered Molho-Pessach, MD, Michal Lotem, MD, Jonathan E. Cohen, MD, PhD
Published in JAAD International (2026-02-01)Get full text
Article